adenosine has been researched along with Cancer of Head in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 15 (65.22) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, H; Huang, J; Li, J; Li, Q; Shen, Y; Shen, Z; Wang, S; Ye, D; Zhan, G; Zhou, C | 1 |
| Hu, G; Li, Y; Liu, C; Lu, T; Pan, M; Wang, Z; Yu, D | 1 |
| Hu, Y; Shen, JX; Xiao, HJ; Zhou, JY; Zhou, LQ | 1 |
| Chen, J; Fang, M; Gong, X; Ji, Y; Li, J; Lu, T; Lv, Q; Tu, Z; Zhong, F | 1 |
| Acton, G; Ay, F; Brennan, PA; Chou, TF; Chudley, L; Davies, JH; Dicker, M; Dobbs, NA; Eschweiler, S; Essame, L; Friberg, G; Hackshaw, A; Halbert, G; Jeffrey, D; Jones, TM; Kelly, F; King, E; Kronenberg, M; Li, Y; Loadman, PM; Lopez-Guadamillas, E; McCann, K; McCaul, JA; Mondal, M; Okkenhaug, K; Ottensmeier, CH; Paterson, C; Ramírez-Suástegui, C; Sacco, JJ; Schache, AG; Seumois, G; Shaw, R; Simon, H; Singh, RP; Thomas, GJ; Thomas, J; Vanhaesebroeck, B; Vijayanand, P; von Witzleben, A; Wang, A; Wilson, W; Wood, O | 1 |
| Bagatini, MD; Basso, HF; Bonadiman, BDSR; de Rocco Donassolo, S; Kosvosky, GC; Marafon, F; Marins, K; Zamoner, A; Zanchi, MM | 1 |
| Chen, J; Feng, Q; Hu, Y; Liu, M; Peng, H | 1 |
| Cui, H; Lan, Z; Yu, GT; Zhao, YY; Zou, KL | 1 |
| Fu, S; Lu, H; Pu, X; Sun, X; Wang, R; Wang, X; Yuan, X | 1 |
| Brand, M; Brunner, C; Doescher, J; Greve, J; Hoffmann, TK; Jackson, EK; Jeske, SS; Laban, S; Schuler, PJ; Ziebart, A | 1 |
| Ban, Y; Cai, J; Hu, M; Li, G; Li, J; Li, X; Mei, Y; Tan, P; Tan, Y; Xiang, B; Xiong, W; Yi, M; Zeng, Z; Zhou, Y | 1 |
| Chen, L; He, Y; Jiang, A; Liu, H; Luo, X; Peng, D; Ren, J; Wang, W; Xie, C; Zeng, Y; Zhang, C; Zhao, Y; Zhou, H | 1 |
| Arumugam, P; George, R; Jayaseelan, VP | 1 |
| Cai, H; Hou, C; Hou, J; Huang, S; Liang, J; Liao, Y; Song, F; Wang, C; Wang, F; Wang, W; Zhang, M; Zhang, Y; Zhu, Y | 1 |
| Golusiński, W; Kosińska, A; Marczak, Ł; Rawłuszko-Wieczorek, AA; Romanowska, K; Suchorska, WM | 1 |
| Chang, CP; Chang, WW; Cheng, YW; Chuang, CY; Lee, H; Lee, YJ; Li, C; Lin, WL; Wu, JS | 1 |
| Arnold, MJ; Balajthy, A; Chimote, AA; Conforti, L; Hajdu, P; Newton, HS; Qualtieri, J; Wise-Draper, T | 1 |
| Avan, A; Bahrami, A; Bahreyni, A; Ebrahimi, S; Ferns, GA; Fiuji, H; Hassanian, SM; Khayami, R; Khazaei, M; Soleimani, A; Toroghian, Y | 1 |
| Brandau, S; Bruderek, K; Dissmann, PA; Dumitru, CA; Jackson, EK; Kansy, BA; Lang, S; Schuler, PJ; Westerkamp, AM | 1 |
| Mandapathil, M | 1 |
| Gorelik, E; Jackson, EK; Johnson, JT; Lang, S; Mandapathil, M; Ren, J; Szajnik, M; Szczepanski, MJ; Whiteside, TL | 1 |
| Harasymczuk, M; Hoffmann, TK; Johnson, J; Lang, S; Schilling, B; Schuler, PJ; Whiteside, TL | 1 |
| Endo-Munoz, L; Gannon, OM; Hazar-Rethinam, M; Merida de Long, L; Saunders, NA | 1 |
3 review(s) available for adenosine and Cancer of Head
| Article | Year |
|---|---|
RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential.
Topics: Adenosine; Animals; Head and Neck Neoplasms; Humans; Immunotherapy; Mammals; RNA; Squamous Cell Carcinoma of Head and Neck | 2023 |
Role of adenosine signaling in the pathogenesis of head and neck cancer.
Topics: Adenosine; Animals; Head and Neck Neoplasms; Humans; Neovascularization, Pathologic; Signal Transduction | 2018 |
Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck.
Topics: Adenosine; Carcinoma, Squamous Cell; Cell Survival; Head and Neck Neoplasms; Humans; Immunity, Innate; Immunomodulation; Immunosuppressive Agents; Models, Immunological; Squamous Cell Carcinoma of Head and Neck | 2016 |
1 trial(s) available for adenosine and Cancer of Head
| Article | Year |
|---|---|
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.
Topics: Adenosine; Animals; Antineoplastic Agents; Disease Models, Animal; Head and Neck Neoplasms; Humans; Immunotherapy; Mice; Phosphatidylinositol 3-Kinases; Quinolines; T-Lymphocytes, Regulatory | 2022 |
19 other study(ies) available for adenosine and Cancer of Head
| Article | Year |
|---|---|
Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Head and Neck Neoplasms; Humans; Immunotherapy; Prognosis; RNA, Long Noncoding; Squamous Cell Carcinoma of Head and Neck; Transcriptome | 2022 |
RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Mice; Mice, Nude; Middle Aged; RNA-Binding Proteins; RNA, Messenger; Snail Family Transcription Factors; Squamous Cell Carcinoma of Head and Neck; Transfection | 2022 |
The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database.
Topics: Adenosine; Aged; Cohort Studies; Computational Biology; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; RNA, Long Noncoding; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2022 |
A Signature of N
Topics: Adenosine; Biomarkers, Tumor; Female; Head and Neck Neoplasms; Humans; Immunity; Male; Middle Aged; Multivariate Analysis; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2022 |
Deregulation of purinergic ectoenzyme activity in head and neck cancer promotes immunosuppression.
Topics: Adenosine; Adenosine Triphosphate; Head and Neck Neoplasms; Humans; Immunosuppression Therapy; Quality of Life; Tumor Microenvironment | 2022 |
IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
Topics: Adenosine; Head and Neck Neoplasms; Humans; Methylation; RNA-Binding Proteins; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck | 2022 |
STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma.
Topics: 5'-Nucleotidase; Adenosine; Animals; Carcinoma, Squamous Cell; Cell Differentiation; Head and Neck Neoplasms; Mice; Mice, Inbred C3H; Monocytes; Mouth Neoplasms; Myeloid-Derived Suppressor Cells; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2023 |
Adenosine-producing regulatory B cells in head and neck cancer.
Topics: Adenine; Adenosine; Agammaglobulinaemia Tyrosine Kinase; Animals; Apoptosis; B-Lymphocytes, Regulatory; Case-Control Studies; Cell Proliferation; Head and Neck Neoplasms; Humans; Male; Mice; Piperidines; Prognosis; Pyrazoles; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
Topics: Adenosine; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; HSP70 Heat-Shock Proteins; Humans; Male; Methylation; Methyltransferases; Middle Aged; Models, Biological; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Proteasome Endopeptidase Complex; Proteolysis; RNA Stability; RNA, Long Noncoding; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Y-Box-Binding Protein 1 | 2020 |
METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.
Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Bleomycin; BRCA1 Protein; Cell Line, Tumor; DNA; Epithelial Cells; Female; Head and Neck Neoplasms; HEK293 Cells; Humans; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Nerve Tissue Proteins; Nucleic Acid Hybridization; Osteoblasts; Phosphorylation; Protein Isoforms; Rad51 Recombinase; Recombinational DNA Repair; Ribonuclease H; RNA Splicing Factors; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Xenograft Model Antitumor Assays | 2020 |
Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
Topics: Adenosine; Carcinogenesis; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; RNA-Binding Proteins; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck | 2021 |
N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Autophagy; Cell Line, Tumor; Eukaryotic Initiation Factor-4G; Female; Head and Neck Neoplasms; Heterografts; Humans; Mice; Mice, Inbred NOD; Mice, SCID; RNA-Binding Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2021 |
The m
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinogenesis; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Mass Spectrometry; Methylation; Methyltransferases; Middle Aged; Poland; RNA; RNA Helicases; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; tRNA Methyltransferases | 2021 |
PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Topics: Adenosine; Aged; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Methylation; Middle Aged; Mouth Neoplasms; Prognosis; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Tumor Cells, Cultured | 2017 |
A defect in KCa3.1 channel activity limits the ability of CD8
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adult; Aged; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Female; Gene Expression; Head and Neck Neoplasms; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Middle Aged; Phenethylamines; Receptor, Adenosine A2A; Tumor Microenvironment | 2018 |
Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Topics: Adenosine; Adenosine Triphosphate; Aged; Biomarkers; Carcinoma, Squamous Cell; Cell Differentiation; Cell Lineage; Cell Proliferation; Female; Head and Neck Neoplasms; Humans; Hydrolysis; Immunophenotyping; Male; Mesenchymal Stem Cells; Middle Aged; Neoplasm Staging; Squamous Cell Carcinoma of Head and Neck | 2017 |
Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.
Topics: 5'-Nucleotidase; Adaptive Immunity; Adenosine; Amino Acids, Cyclic; Antigens, CD; Apyrase; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immune Tolerance; Intracellular Space; Signal Transduction; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2010 |
Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
Topics: Adenosine; Adenosine Triphosphate; Adult; Aged; Carcinoma, Squamous Cell; CTLA-4 Antigen; Female; Flow Cytometry; Forkhead Transcription Factors; Head and Neck Neoplasms; Humans; Interleukin-2 Receptor alpha Subunit; Leukocytes, Mononuclear; Lymphocytes, Tumor-Infiltrating; Male; Membrane Proteins; Middle Aged; Programmed Cell Death 1 Receptor; Receptors, Interleukin-1 Type I; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2012 |
Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
Topics: Adenosine; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histones; Humans; Methylation; Mice; Polycomb Repressive Complex 2; RNA Interference; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous | 2013 |